==The Beauty Health Company (SKIN) reported earnings on Tue 12 March 24 (a/h)

 

The Beauty Health Company reports EPS in-line, beats on revs; guides Q1 revs below consensus; FY24 revenue guidance in-line

• Reports Q4 (Dec) loss of ($0.07) per share, in-line with the FactSet Consensus of ($0.07); revenues fell 1.3% year/year to $96.8 mln vs the $87.22 mln FactSet Consensus.
• Co issues downside guidance for Q1, sees Q1 revs of $77-83 mln vs. $85.50 mln FactSet Consensus.
• Co expects FY24 revenue growth to be flat to low-single digits compared to 0.5% FactSet Consensus.